Wells Fargo & Company Bausch Health Companies Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 24,011 shares of BHC stock, worth $183,684. This represents 0.0% of its overall portfolio holdings.

Number of Shares

24,011

Previous 30,883 22.25%

Holding current value

$183,684

Previous $215,000 9.3%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$5.22 - $8.26 $35,871 - $56,762	-6,872 Reduced 22.25%	24,011 $195,000
Q2 2024 Aug 13, 2024	BUY	$6.1 - $10.41 $35,904 - $61,273	5,886 Added 23.55%	30,883 $215,000
Q1 2024 May 10, 2024	SELL	$7.77 - $10.61 $1.38 Million - $1.88 Million	-177,559 Reduced 87.66%	24,997 $265,000
Q4 2023 Feb 09, 2024	BUY	$6.53 - $8.23 $1.12 Million - $1.42 Million	172,215 Added 567.6%	202,556 $1.62 Million
Q3 2023 Nov 13, 2023	SELL	$7.69 - $9.71 $26,061 - $32,907	-3,389 Reduced 10.05%	30,341 $249,000
Q2 2023 Aug 15, 2023	SELL	$5.72 - $8.8 $11,788 - $18,136	-2,061 Reduced 5.76%	33,730 $269,000
Q1 2023 May 12, 2023	SELL	$6.28 - $9.85 $232,724 - $365,021	-37,058 Reduced 50.87%	35,791 $289,000
Q4 2022 Feb 13, 2023	BUY	$6.09 - $7.93 $182,730 - $237,939	30,005 Added 70.03%	72,849 $457,000
Q3 2022 Nov 14, 2022	SELL	$4.58 - $9.21 $2.04 Million - $4.1 Million	-445,318 Reduced 91.22%	42,844 $296,000
Q2 2022 Aug 12, 2022	BUY	$7.06 - $23.63 $2,711 - $9,073	384 Added 0.08%	488,162 $4.07 Million
Q1 2022 May 16, 2022	SELL	$21.6 - $27.79 $1.1 Million - $1.42 Million	-51,086 Reduced 9.48%	487,778 $11.1 Million
Q4 2021 Feb 14, 2022	SELL	$23.0 - $29.01 $795,846 - $1 Million	-34,602 Reduced 6.03%	538,864 $14.9 Million
Q3 2021 Nov 15, 2021	BUY	$25.04 - $30.06 $1.2 Million - $1.44 Million	47,860 Added 9.11%	573,466 $16 Million
Q2 2021 Aug 16, 2021	SELL	$27.43 - $32.7 $13 Million - $15.6 Million	-475,669 Reduced 47.51%	525,606 $15.4 Million
Q1 2021 May 13, 2021	SELL	$21.37 - $34.38 $505,571 - $813,362	-23,658 Reduced 2.31%	1,001,275 $31.8 Million
Q4 2020 Feb 09, 2021	SELL	$15.31 - $21.12 $3.97 Million - $5.47 Million	-259,223 Reduced 20.19%	1,024,933 $21.3 Million
Q3 2020 Nov 05, 2020	BUY	$14.88 - $20.13 $5.32 Million - $7.2 Million	357,560 Added 38.59%	1,284,156 $20 Million
Q2 2020 Aug 13, 2020	BUY	$13.31 - $20.51 $8.76 Million - $13.5 Million	657,861 Added 244.8%	926,596 $16.9 Million
Q1 2020 May 14, 2020	BUY	$12.98 - $30.25 $3.49 Million - $8.13 Million	268,735 New	268,735 $4.17 Million

Others Institutions Holding BHC

# of Institutions

254

Shares Held

253M

Call Options Held

5.53M

Put Options Held

16.5M

View Full List

About Bausch Health Companies Inc.

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.77B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

More about BHC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Bausch Health Companies Inc. Transaction History